Market Overview

Karyopharm Therapeutics (NASDAQ: KPTI)

17.19 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/03/20Morgan StanleyMaintainsOverweight32.0
11/03/20SVB LeerinkMaintainsOutperform28.0
8/04/20SVB LeerinkMaintainsOutperform30.0
7/02/20Morgan StanleyInitiates Coverage OnOverweight34.0
6/23/20WedbushMaintainsNeutral26.0
6/23/20HC Wainwright & Co.MaintainsBuy41.0
5/06/20HC Wainwright & Co.MaintainsBuy40.0
5/05/20SVB LeerinkMaintainsOutperform29.0
3/04/20BarclaysInitiates Coverage OnOverweight30.0
3/02/20HC Wainwright & Co.MaintainsBuy43.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter